Amanda Kathleen Lukens, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Antimalarials | 25 | 2024 | 907 | 3.440 |
Why?
|
Plasmodium falciparum | 33 | 2024 | 1742 | 2.720 |
Why?
|
Malaria, Falciparum | 16 | 2024 | 1077 | 1.630 |
Why?
|
Oxidoreductases Acting on CH-CH Group Donors | 4 | 2023 | 174 | 1.600 |
Why?
|
Parasites | 5 | 2023 | 160 | 1.230 |
Why?
|
Drug Resistance | 14 | 2024 | 1596 | 1.180 |
Why?
|
Malaria | 7 | 2021 | 1227 | 1.010 |
Why?
|
Drug Discovery | 7 | 2021 | 1051 | 0.910 |
Why?
|
Enzyme Inhibitors | 5 | 2021 | 3712 | 0.840 |
Why?
|
Protozoan Proteins | 7 | 2024 | 847 | 0.810 |
Why?
|
Acetate-CoA Ligase | 1 | 2021 | 9 | 0.780 |
Why?
|
Cytochromes b | 2 | 2016 | 35 | 0.520 |
Why?
|
Plasmodium | 4 | 2022 | 246 | 0.490 |
Why?
|
Amino Acyl-tRNA Synthetases | 3 | 2022 | 88 | 0.460 |
Why?
|
Genetic Fitness | 1 | 2013 | 115 | 0.420 |
Why?
|
Chloroquine | 1 | 2013 | 274 | 0.400 |
Why?
|
Genome, Protozoan | 3 | 2024 | 152 | 0.260 |
Why?
|
Parasitic Sensitivity Tests | 3 | 2021 | 89 | 0.260 |
Why?
|
Directed Molecular Evolution | 2 | 2024 | 162 | 0.260 |
Why?
|
Drug Resistance, Multiple | 2 | 2024 | 255 | 0.250 |
Why?
|
Selection, Genetic | 5 | 2018 | 868 | 0.250 |
Why?
|
Drug Evaluation, Preclinical | 4 | 2018 | 1334 | 0.230 |
Why?
|
Molecular Structure | 4 | 2021 | 1880 | 0.210 |
Why?
|
High-Throughput Screening Assays | 3 | 2018 | 934 | 0.200 |
Why?
|
Quinazolinones | 3 | 2022 | 221 | 0.190 |
Why?
|
Folic Acid Antagonists | 1 | 2021 | 75 | 0.190 |
Why?
|
Small Molecule Libraries | 3 | 2014 | 733 | 0.180 |
Why?
|
Structure-Activity Relationship | 5 | 2016 | 3076 | 0.160 |
Why?
|
Life Cycle Stages | 2 | 2016 | 160 | 0.160 |
Why?
|
Eukaryotic Initiation Factor-2 | 1 | 2019 | 181 | 0.150 |
Why?
|
Proline | 1 | 2019 | 457 | 0.140 |
Why?
|
DNA Copy Number Variations | 2 | 2023 | 2020 | 0.140 |
Why?
|
Piperidines | 4 | 2022 | 1656 | 0.140 |
Why?
|
Genes, Protozoan | 4 | 2024 | 170 | 0.130 |
Why?
|
Chemoprevention | 1 | 2018 | 326 | 0.130 |
Why?
|
Malaria Vaccines | 1 | 2017 | 165 | 0.130 |
Why?
|
Lactams, Macrocyclic | 2 | 2014 | 318 | 0.130 |
Why?
|
Toxoplasmosis | 1 | 2016 | 94 | 0.130 |
Why?
|
Quinolines | 1 | 2021 | 764 | 0.130 |
Why?
|
Coordination Complexes | 1 | 2016 | 73 | 0.130 |
Why?
|
Plasmodium berghei | 1 | 2016 | 159 | 0.130 |
Why?
|
Antigens, Protozoan | 1 | 2017 | 316 | 0.130 |
Why?
|
Azetidines | 1 | 2016 | 142 | 0.120 |
Why?
|
Toxoplasma | 1 | 2016 | 157 | 0.120 |
Why?
|
Phenylurea Compounds | 2 | 2016 | 529 | 0.120 |
Why?
|
Lassa virus | 1 | 2015 | 99 | 0.120 |
Why?
|
Base Sequence | 3 | 2014 | 12441 | 0.120 |
Why?
|
Pyrimidines | 3 | 2019 | 3028 | 0.120 |
Why?
|
Lassa Fever | 1 | 2015 | 97 | 0.120 |
Why?
|
Molecular Sequence Data | 4 | 2014 | 17635 | 0.110 |
Why?
|
Chemistry, Pharmaceutical | 1 | 2014 | 274 | 0.110 |
Why?
|
Antigens, Surface | 1 | 2017 | 1606 | 0.110 |
Why?
|
Models, Molecular | 2 | 2021 | 5439 | 0.110 |
Why?
|
Niacinamide | 1 | 2015 | 413 | 0.110 |
Why?
|
Ubiquinone | 1 | 2014 | 183 | 0.110 |
Why?
|
Point Mutation | 2 | 2019 | 1595 | 0.110 |
Why?
|
Triazoles | 2 | 2019 | 903 | 0.110 |
Why?
|
Erythrocytes | 3 | 2017 | 2413 | 0.100 |
Why?
|
Quinolones | 1 | 2016 | 378 | 0.100 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2022 | 1841 | 0.100 |
Why?
|
Senegal | 4 | 2013 | 256 | 0.100 |
Why?
|
Genetic Loci | 2 | 2012 | 2632 | 0.100 |
Why?
|
Catalytic Domain | 1 | 2014 | 705 | 0.100 |
Why?
|
Genome, Viral | 1 | 2015 | 667 | 0.100 |
Why?
|
DNA, Protozoan | 1 | 2012 | 228 | 0.090 |
Why?
|
Saccharomyces cerevisiae | 1 | 2022 | 2688 | 0.090 |
Why?
|
Malaria, Cerebral | 1 | 2012 | 136 | 0.090 |
Why?
|
Drug Synergism | 1 | 2014 | 1755 | 0.090 |
Why?
|
Benzimidazoles | 1 | 2014 | 858 | 0.080 |
Why?
|
Quinazolines | 1 | 2015 | 1371 | 0.080 |
Why?
|
Oxidation-Reduction | 1 | 2014 | 2231 | 0.080 |
Why?
|
Animals | 17 | 2023 | 168459 | 0.070 |
Why?
|
Polymorphism, Single Nucleotide | 6 | 2016 | 15936 | 0.070 |
Why?
|
Indoles | 1 | 2015 | 1833 | 0.070 |
Why?
|
RNA, Viral | 1 | 2015 | 2846 | 0.070 |
Why?
|
Genome-Wide Association Study | 3 | 2016 | 12690 | 0.070 |
Why?
|
Liver | 3 | 2016 | 7529 | 0.070 |
Why?
|
Sequence Analysis, DNA | 2 | 2013 | 4740 | 0.060 |
Why?
|
Genome | 1 | 2013 | 1740 | 0.060 |
Why?
|
Analysis of Variance | 1 | 2013 | 6228 | 0.060 |
Why?
|
Inhibitory Concentration 50 | 2 | 2014 | 465 | 0.050 |
Why?
|
Humans | 21 | 2024 | 761504 | 0.050 |
Why?
|
Frameshift Mutation | 1 | 2024 | 392 | 0.050 |
Why?
|
Genotype | 6 | 2013 | 12990 | 0.050 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2014 | 3639 | 0.050 |
Why?
|
Xenobiotics | 1 | 2022 | 70 | 0.050 |
Why?
|
Ligases | 1 | 2023 | 333 | 0.050 |
Why?
|
Cell Survival | 3 | 2016 | 5791 | 0.050 |
Why?
|
Trophoblasts | 1 | 2002 | 224 | 0.050 |
Why?
|
RNA, Transfer | 1 | 2022 | 292 | 0.040 |
Why?
|
Genetic Variation | 3 | 2015 | 6567 | 0.040 |
Why?
|
Heme | 1 | 2021 | 313 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2016 | 10766 | 0.040 |
Why?
|
Gene Expression Regulation, Fungal | 1 | 2022 | 495 | 0.040 |
Why?
|
Principal Component Analysis | 2 | 2012 | 943 | 0.040 |
Why?
|
Time | 1 | 2021 | 546 | 0.040 |
Why?
|
Chromosome Mapping | 1 | 2006 | 4615 | 0.040 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2021 | 563 | 0.040 |
Why?
|
Disease Models, Animal | 4 | 2019 | 18252 | 0.040 |
Why?
|
Phenylalanine-tRNA Ligase | 1 | 2016 | 15 | 0.030 |
Why?
|
Oocysts | 1 | 2016 | 16 | 0.030 |
Why?
|
Parasite Egg Count | 1 | 2016 | 29 | 0.030 |
Why?
|
Linkage Disequilibrium | 2 | 2012 | 1998 | 0.030 |
Why?
|
Mutation | 5 | 2023 | 30052 | 0.030 |
Why?
|
Azabicyclo Compounds | 1 | 2016 | 68 | 0.030 |
Why?
|
Murinae | 1 | 2015 | 18 | 0.030 |
Why?
|
Membrane Transport Proteins | 1 | 2021 | 1035 | 0.030 |
Why?
|
Mutation, Missense | 1 | 2024 | 2571 | 0.030 |
Why?
|
Africa, Western | 1 | 2015 | 159 | 0.030 |
Why?
|
INDEL Mutation | 1 | 2016 | 266 | 0.030 |
Why?
|
Disease Reservoirs | 1 | 2015 | 121 | 0.030 |
Why?
|
Cats | 1 | 2016 | 975 | 0.030 |
Why?
|
Ether-A-Go-Go Potassium Channels | 1 | 2014 | 72 | 0.030 |
Why?
|
Artemisinins | 1 | 2016 | 218 | 0.030 |
Why?
|
Mice, SCID | 1 | 2019 | 2626 | 0.030 |
Why?
|
Zoonoses | 1 | 2015 | 179 | 0.030 |
Why?
|
Hep G2 Cells | 1 | 2015 | 379 | 0.030 |
Why?
|
Half-Life | 1 | 2015 | 651 | 0.030 |
Why?
|
Gene Frequency | 2 | 2012 | 3606 | 0.030 |
Why?
|
Biological Availability | 1 | 2014 | 390 | 0.030 |
Why?
|
Killer Cells, Natural | 1 | 2002 | 2200 | 0.030 |
Why?
|
Amines | 1 | 2015 | 281 | 0.030 |
Why?
|
Guinea Pigs | 1 | 2015 | 1310 | 0.030 |
Why?
|
Cytosol | 1 | 2016 | 888 | 0.030 |
Why?
|
Computer-Aided Design | 1 | 2015 | 300 | 0.030 |
Why?
|
Multilocus Sequence Typing | 1 | 2013 | 100 | 0.030 |
Why?
|
Mice, Inbred BALB C | 2 | 2017 | 6216 | 0.030 |
Why?
|
Ebolavirus | 1 | 2015 | 251 | 0.030 |
Why?
|
Solubility | 1 | 2014 | 1091 | 0.030 |
Why?
|
Clone Cells | 1 | 2016 | 1659 | 0.030 |
Why?
|
Gambia | 1 | 2012 | 104 | 0.030 |
Why?
|
Population Density | 1 | 2013 | 193 | 0.030 |
Why?
|
Nigeria | 1 | 2015 | 770 | 0.030 |
Why?
|
Drug Resistance, Microbial | 1 | 2015 | 825 | 0.020 |
Why?
|
DNA Barcoding, Taxonomic | 1 | 2013 | 132 | 0.020 |
Why?
|
Safety | 1 | 2016 | 1150 | 0.020 |
Why?
|
Genetics, Population | 1 | 2016 | 937 | 0.020 |
Why?
|
Mefloquine | 1 | 2011 | 55 | 0.020 |
Why?
|
Molecular Typing | 1 | 2012 | 116 | 0.020 |
Why?
|
Parasitemia | 1 | 2012 | 165 | 0.020 |
Why?
|
Phenanthrenes | 1 | 2011 | 66 | 0.020 |
Why?
|
Malawi | 1 | 2012 | 304 | 0.020 |
Why?
|
Ethanolamines | 1 | 2011 | 153 | 0.020 |
Why?
|
Transcription Factors | 2 | 2022 | 12128 | 0.020 |
Why?
|
Hemorrhagic Fever, Ebola | 1 | 2015 | 420 | 0.020 |
Why?
|
Phylogeny | 2 | 2008 | 2811 | 0.020 |
Why?
|
Fluorenes | 1 | 2011 | 157 | 0.020 |
Why?
|
Drug Design | 1 | 2015 | 1048 | 0.020 |
Why?
|
Macaca mulatta | 1 | 2016 | 2329 | 0.020 |
Why?
|
Feces | 1 | 2016 | 1497 | 0.020 |
Why?
|
Biological Evolution | 1 | 2015 | 1071 | 0.020 |
Why?
|
Blood | 1 | 2012 | 596 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2005 | 9420 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2016 | 16981 | 0.020 |
Why?
|
Metabolomics | 1 | 2018 | 1659 | 0.020 |
Why?
|
Viral Proteins | 1 | 2015 | 1804 | 0.020 |
Why?
|
Cell Membrane | 1 | 2017 | 3688 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2005 | 7856 | 0.020 |
Why?
|
Phosphorylation | 1 | 2019 | 8320 | 0.020 |
Why?
|
Glycoproteins | 1 | 2015 | 2203 | 0.020 |
Why?
|
Genetic Linkage | 1 | 2013 | 2341 | 0.020 |
Why?
|
Proteome | 1 | 2017 | 1862 | 0.020 |
Why?
|
Epidemics | 1 | 2013 | 512 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2016 | 4278 | 0.020 |
Why?
|
Central America | 1 | 2006 | 69 | 0.020 |
Why?
|
Seasons | 1 | 2013 | 1520 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2005 | 11903 | 0.020 |
Why?
|
South America | 1 | 2006 | 179 | 0.020 |
Why?
|
Gene Dosage | 1 | 2011 | 1217 | 0.020 |
Why?
|
Alleles | 1 | 2018 | 6863 | 0.020 |
Why?
|
Prevalence | 2 | 2013 | 15732 | 0.020 |
Why?
|
Mice | 4 | 2016 | 81525 | 0.020 |
Why?
|
Mitochondria | 1 | 2018 | 3624 | 0.020 |
Why?
|
RNA, Protozoan | 1 | 2005 | 45 | 0.020 |
Why?
|
Asia | 1 | 2006 | 619 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2012 | 2707 | 0.020 |
Why?
|
Haplotypes | 1 | 2011 | 2713 | 0.010 |
Why?
|
Africa | 1 | 2006 | 709 | 0.010 |
Why?
|
Proteomics | 1 | 2017 | 3849 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2811 | 0.010 |
Why?
|
Host-Parasite Interactions | 1 | 2005 | 300 | 0.010 |
Why?
|
H-2 Antigens | 1 | 2002 | 357 | 0.010 |
Why?
|
Phenotype | 1 | 2019 | 16591 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2011 | 2735 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 2002 | 867 | 0.010 |
Why?
|
Choristoma | 1 | 2002 | 206 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2005 | 2748 | 0.010 |
Why?
|
Female | 6 | 2019 | 392644 | 0.010 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2002 | 1351 | 0.010 |
Why?
|
Rats | 1 | 2015 | 23742 | 0.010 |
Why?
|
Gene Expression | 1 | 2011 | 7581 | 0.010 |
Why?
|
Adaptation, Physiological | 1 | 2005 | 1301 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2005 | 3778 | 0.010 |
Why?
|
Signal Transduction | 1 | 2019 | 23445 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2013 | 20098 | 0.010 |
Why?
|
Time Factors | 1 | 2015 | 39967 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2005 | 13446 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2005 | 7594 | 0.010 |
Why?
|
Child | 2 | 2012 | 80153 | 0.010 |
Why?
|
Male | 3 | 2016 | 360804 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2005 | 12795 | 0.010 |
Why?
|
Infant | 1 | 2012 | 36192 | 0.010 |
Why?
|
Graft Rejection | 1 | 2002 | 4445 | 0.010 |
Why?
|
Child, Preschool | 1 | 2012 | 42230 | 0.000 |
Why?
|
Young Adult | 1 | 2013 | 59243 | 0.000 |
Why?
|
Adult | 2 | 2013 | 221177 | 0.000 |
Why?
|
Adolescent | 1 | 2013 | 88319 | 0.000 |
Why?
|
Mice, Inbred C57BL | 1 | 2002 | 22169 | 0.000 |
Why?
|
Pregnancy | 1 | 2002 | 29874 | 0.000 |
Why?
|